Shares of Sudharshan Pharma Industries surged 5% and hit the upper circuit at ₹27.80 during Friday’s early trade (April 25, 2025), even as broader markets slipped into the red. The BSE Sensex was down by 174.24 points at 79,627.19, while the Nifty fell 94.35 points to 24,152.35.
The stock opened strong at ₹27.80, rising from its previous close of ₹27.26. Its 52-week high stands at ₹53.50, while the 52-week low is ₹5.82. Over the last year, the scrip has delivered a multibagger return of 252%, and 275% over two years. However, it has declined 39.31% year-to-date in 2025.
Sudharshan Pharma Quarterly Performance Boosts Investor Sentiment
The rally follows the release of the company’s Q4 FY2024-25 results. As per exchange filings, standalone revenue increased by 20% YoY from ₹232 crore in Q4FY24 to ₹277 crore in Q4FY25. On a quarterly basis, revenue rose 21.5%, up from ₹228 crore in Q3FY25.
Net profit for the quarter jumped 50% YoY, rising from ₹6.60 crore to ₹10 crore, although this figure includes a non-operating income of ₹1.65 crore from the sale of an Extended Producer Responsibility (EPR) certificate.
Global Market Overview
Despite the domestic market dip, Asian indices like South Korea’s Kospi, Japan’s Nikkei 225, China’s SSE Composite, and Hong Kong’s Hang Seng traded positively.
In the U.S., markets closed sharply higher on Thursday. The Nasdaq soared 2.74%, the S&P 500 gained 2.03%, and the Dow Jones added 1.23%.
Foreign Institutional Investors (FIIs) were net buyers, investing ₹8,250.53 crore in Indian equities. Meanwhile, Brent crude oil rose 0.53% to $66.90 per barrel.
1 thought on “Sudharshan Pharma Shares Hit Upper Circuit Amid Market Weakness on April 25, 2025”